fatigue - HealthQuill

The US Food and Drug Administration (FDA) has granted an accelerated approval for AbbVie Inc.’s drug to treat a specific group of adult lung cancer patients who have tried other systemic treatments.

AbbVie’s NSCLC lung cancer drug gets accelerated approval from FDA

HQ Team May 15, 2025: The US Food and Drug Administration (FDA) has granted an accelerated approval for AbbVie Inc.’s drug to treat.

by HealthQuill
May 15, 2025
0 Comments

The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating thyroid eye disease, according to a statement.

Drugs Medical Pharma

Amgen’s thyroid eye disease medicine gets EU market authorisation

HQ Team April 27, 2025: The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating.

by HealthQuill
April 27, 2025
0 Comments

The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.

Drugs Health Pharma

Ionis Pharma’s drug to treat rare genetic disease gets US regulator’s nod

The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia.

by HealthQuill
December 20, 2024
0 Comments

overuse of cannabis can result in impaired memory

Drugs Health Pharma

FDA clears Akebia’s drug to treat anaemia in acute kidney disease

HQ Team March 28, 2024: Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulator’s approval for its Vafseo drug to treat anaemia.